Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Asset Utilization Ratio: 2024-2025

Historic Asset Utilization Ratio for Krystal Biotech (KRYS) over the last 2 years, with Sep 2025 value amounting to 0.31.

  • Krystal Biotech's Asset Utilization Ratio rose 23.39% to 0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31, marking a year-over-year increase of 23.39%. This contributed to the annual value of 0.31 for FY2024, which is 320.94% up from last year.
  • Latest data reveals that Krystal Biotech reported Asset Utilization Ratio of 0.31 as of Q3 2025, which was down 3.35% from 0.32 recorded in Q2 2025.
  • Over the past 5 years, Krystal Biotech's Asset Utilization Ratio peaked at 0.32 during Q2 2025, and registered a low of 0.11 during Q1 2024.
  • In the last 2 years, Krystal Biotech's Asset Utilization Ratio had a median value of 0.29 in 2024 and averaged 0.26.
  • Data for Krystal Biotech's Asset Utilization Ratio shows a peak YoY spiked of 176.88% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Krystal Biotech's Asset Utilization Ratio stood at 0.29 in 2024, then grew by 23.39% to 0.31 in 2025.
  • Its Asset Utilization Ratio stands at 0.31 for Q3 2025, versus 0.32 for Q2 2025 and 0.31 for Q1 2025.